Nadine Andrieu

6PUBLICATIONS
39CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targetsCancer geneticsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 10, 2025
Body Mass Index, IGF1-Related Polymorphisms, and Risk of Familial Breast Cancer in Women with No BRCA1 or BRCA2 Pathogenic Variant.

Barbara Fritsch-Humblet, Yue Jiao, Séverine Eon-Marchais

|Jun 04, 2025
Breast Density Changes after Risk-Reducing Salpingo-oophorectomy in Women with a Pathogenic Germline Variant in BRCA1 or BRCA2.

Elizabeth A Loehrer, Frederieke H van der Baan, Thea M Mooij

|Mar 12, 2025
Breast tumors from ATM pathogenic variant carriers display a specific genome-wide DNA methylation profile.

Nicolas M Viart, Anne-Laure Renault, Séverine Eon-Marchais

|Jan 20, 2022
Oral Contraceptive Use in BRCA1 and BRCA2 Mutation Carriers: Absolute Cancer Risks and Benefits.

Lieske H Schrijver, Thea M Mooij, Anouk Pijpe

|Aug 04, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.

Maximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais

|Jun 14, 2021
First international workshop of the ATM and cancer risk group (4-5 December 2019).

Fabienne Lesueur, Douglas F Easton, Anne-Laure Renault

Pageof 1

Frequent Collaborators

2 joint publications

Dorothée Le Gal

2 joint publications

Dominique Stoppa-Lyonnet

2 joint publications

Antonis C Antoniou

2 joint publications

Douglas F Easton